Search
Prazosin
go.drugbank.com/drugs/DB00457ApprovedInvestigationalPrazosin is marketed by _Pfizer_ and was initially approved by the FDA in 1988.[L5828] It belongs to the class of drugs known as alpha-1 antagonists. … Recently, many studies have evaluated the benefits of this drug in controlling the symptoms of post-traumatic stress disorder (PTSD) and associated nightmares.[A176618, A176621, A176624]
Products: NOPRES 2 MG TABLET, 100 ADET, MIZOSIN TABLET 1 mgImipramine
go.drugbank.com/drugs/DB00458ApprovedInvestigationalImipramine may be used to treat depression and nocturnal enuresis in children [FDA Label]. … In depressed individuals, imipramine exerts a positive effect on mood. TCAs are potent inhibitors of serotonin and norepinephrine reuptake.
Synonyms: 10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine, N-(γ-dimethylaminopropyl)iminodibenzylProducts: IMIPRAMIN-NEURAX 100 MG, TOFRANİL 25 MG KAPLI TABLET, 100 ADETDacomitinib
go.drugbank.com/drugs/DB11963ApprovedInvestigational[L4810] Some evidence in the literature suggests the therapeutic potential of dacomitinib in the epithelial ovarian cancer model[A39624], although further investigations are needed. … Dacomitinib, designed as (2E)-N-16-4-(piperidin-1-yl) but-2-enamide, is an oral highly selective quinazalone part of the second-generation tyrosine kinase inhibitors which are characterized by the irreversible
Products: Vizimpro 30 mg Film-Coated Tablets, Vizimpro 15 mg Film-Coated TabletsUpadacitinib
go.drugbank.com/drugs/DB15091ApprovedInvestigationalMore recently, it has also been approved for the treatment of giant cell arteritis in adults and active polyarticular juvenile idiopathic arthritis in patients aged 2 years and older.[L10896] … Upadacitinib is an oral Janus kinase (JAK)1-selective inhibitor and a disease-modifying antirheumatic drug (DMARD) used in the treatment of rheumatoid arthritis to slow down disease progression.
Products: RİNVOQ 15 MG UZATILMIŞ SALIMLI TABLET, 98 ADET, Rinvoq 45 mg Uzatılmış Salımlı Tablet, 28 ADETEplerenone
go.drugbank.com/drugs/DB00700ApprovedInvestigationalEplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative … regulatory feedback of aldosterone on renin secretion.
Products: EPLEDAY 25 MG FILM KAPLI TABLET, 100 ADET, EPLEDAY 50 MG FILM KAPLI TABLET, 100 ADETThiamphenicol
go.drugbank.com/drugs/DB08621InvestigationalProducts: TİOFEN 250 MG TABLET, 16 TABLET, URFETEM 250 MG KAPSUL (16 KAPSUL)Oxymetazoline
go.drugbank.com/drugs/DB00935ApprovedInvestigational[L15057] In July 2020, the FDA approved the use of an ophthalmic formulation of oxymetazoline (Upneeq) in adults with acquired blepharoptosis, or ptosis, making it the first FDA-approved medical treatment … [A215587, L15092] In dentistry, oxymetazoline and tetracaine combination intranasal spray (Kovanaze) is used for regional anesthesia during dental procedures in children and adults.
Mixtures: N-S-4Products: OKSINAZAL % 0.05 BURUN SPREYİ 15 ML LİK ŞİŞEDE 10 ML 200 DOZ, OXIFREE®0.25 MG/ MLErdafitinib
go.drugbank.com/drugs/DB12147ApprovedInvestigational[L5956, L5959] Considering urothelial cancer is statistically the fourth most common kind of cancer in the world, the introduction of erdafitinib offers a much-needed new option in the ever-expanding therapeutic … In early April of 2019, the US FDA approved Janssen Pharmaceutical Companies' brand name Balversa (erdafitinib) as the first-ever fibroblast growth factor receptor (FGFR) kinase inhibitor indicated for
Products: BALVERSA 3 MG FİLM KAPLI TABLET, 56 ADET, BALVERSA 3 MG FİLM KAPLI TABLET, 84 ADETNitrofural
go.drugbank.com/drugs/DB00336ApprovedVet approvedWithdrawnIt is used for superficial wounds, burns, ulcers, and skin infections. Nitrofural has also been administered orally in the treatment of trypanosomiasis.
Products: FURAZOL KULAK DAMLASI 20 ML, NITROFURAZONA 0.2 G / 100 G UNGUENTOFlumethasone
go.drugbank.com/drugs/DB00663ApprovedVet approvedThis local effect on diseased areas results in a prompt decrease in inflammation, exudation and itching.
Mixtures: LOCACORTENE VİOFORME 0,2 MG/G+30 MG/G KREM, 15 G, LOCACORTENE VİOFORME 0,2 MG/G+30 MG/G KREM, 30 GProducts: CERSON 0.2 MG/G CREME, CERSON 0.2 MG/G FETTCREME